missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ Pexidartinib
Potent CSF-1R inhibitor
159.82 € - 563.70 €
Specifications
| Chemical Name or Material | N-[5-[(5-Chloro-1 H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine |
|---|---|
| CAS | 1029044-16-3 |
| Target | Additional RTK Inhibitors |
| Molecular Formula | C20H15ClF3N5 |
| Purity | 98% |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18717136
|
Tocris Bioscience™
7590/10 |
10 mg |
159.82 €
10mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18706716
|
Tocris Bioscience™
7590/50 |
50 mg |
563.70 €
50mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Pexidartinib is a potent colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase inhibitor (IC50 = 20 nM). In the B16F10 mouse melanoma model, Pexidartinib reduces the systemic and local accumulation of macrophages without affecting Gr-1+ myeloid derived suppressor cells. When combined with tumor-specific CD8 T cell immunotherapy, Pexidartinib promotes the control of tumor growth. In the BRAFV600E-driven mouse melanoma model, Pexidartinib improves the efficacy of adoptive cell therapy with reduction of TIMs and an increase in tumor-infiltrating lymphocytes and T cells. Orally bioavailable.Specifications
| N-[5-[(5-Chloro-1 H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine | |
| Additional RTK Inhibitors | |
| 98% |
| 1029044-16-3 | |
| C20H15ClF3N5 |
Safety and Handling
Recommended Storage : Store at -20°C